Free Trial

Top Penny Stocks To Watch Today - July 25th

AEye logo with Computer and Technology background

Key Points

  • AEye, Inc., a lidar systems provider, saw its shares rise to $4.38 during mid-day trading with a significant trading volume of 315,522,504 shares.
  • Opendoor Technologies, which operates a digital platform for real estate transactions, traded up to $2.49, with substantial trading activity exceeding 203 million shares.
  • Incannex Healthcare, a clinical stage pharmaceutical company, experienced a decline in its shares to $1.09, despite a high trading volume of nearly 199 million shares.
  • These three stocks are highlighted as top penny stocks to watch due to their recent trading volumes and price movements.
  • MarketBeat previews the top five stocks to own by August 1st.
  • Limited Time Offer: Unlock powerful research tools, advanced financial data, and expert insights to help you invest with confidence. Save 50% when you upgrade to MarketBeat All Access during the month of July. Claim your discount here.

AEye, Opendoor Technologies, and Incannex Healthcare are the three Penny stocks to watch today, according to MarketBeat's stock screener tool. Penny stocks are shares of small public companies that trade at low per‐share prices—often below $5 in the U.S.—and typically have modest market capitalizations. Because they’re thinly traded, they often suffer from low liquidity and wide bid-ask spreads. This combination of factors can lead to extreme price volatility and elevated risk of manipulation or fraud. These companies had the highest dollar trading volume of any Penny stocks within the last several days.

AEye (LIDR)

AEye, Inc., together with its subsidiaries, provides lidar systems for vehicle autonomy, advanced driver-assistance systems, and robotic vision applications in the United States, Europe, and Asia-Pacific. It offers 4Sight intelligent sensing lidar platform, including 4Sight at Design, Triggered 4Sight, Responsive 4Sight, and Predictive 4Sight; and 4Sight for automotive and industrial market.

Shares of NASDAQ:LIDR traded up $1.46 during mid-day trading on Friday, reaching $4.38. The stock had a trading volume of 315,522,504 shares, compared to its average volume of 6,503,229. The company has a current ratio of 2.50, a quick ratio of 2.49 and a debt-to-equity ratio of 0.01. The company has a market cap of $84.25 million, a P/E ratio of -1.21 and a beta of 2.77. AEye has a 1 year low of $0.49 and a 1 year high of $5.36. The business's 50 day moving average price is $0.94 and its 200 day moving average price is $0.85.

Read Our Latest Research Report on LIDR

Opendoor Technologies (OPEN)

Opendoor Technologies Inc. operates a digital platform for residential real estate transactions in the United States. It buys and sells homes. The company's product offerings comprise sell to opendoor product that enables homeowners to sell their home directly to it and resell the home to a home buyer; list with opendoor product that allows customers to list their home on the MLS with opendoor and receive cash offer; and opendoor marketplace product that connects the home seller with an institutional or retail buyer.

Opendoor Technologies stock traded up $0.07 during midday trading on Friday, reaching $2.49. The stock had a trading volume of 203,767,367 shares, compared to its average volume of 99,293,086. The company has a quick ratio of 0.75, a current ratio of 2.99 and a debt-to-equity ratio of 2.43. The company has a fifty day moving average of $0.88 and a 200 day moving average of $1.08. Opendoor Technologies has a 52-week low of $0.51 and a 52-week high of $4.97. The firm has a market cap of $1.81 billion, a price-to-earnings ratio of -4.78 and a beta of 2.78.

Read Our Latest Research Report on OPEN

Incannex Healthcare (IXHL)

Incannex Healthcare Inc., a clinical stage pharmaceutical development company, engages in the research, development, and sale of medicinal cannabinoid and psychedelic pharmaceutical products and therapies. It develops products for the treatment of obstructive sleep apnoea (OSA), traumatic brain injury (TBI) and concussion, lung inflammation (ARDS, COPD, asthma, bronchitis), rheumatoid arthritis, inflammatory bowel disease, anxiety disorders, addiction disorders, pain, and other indications.

Shares of IXHL stock traded down $0.54 on Friday, hitting $1.09. The stock had a trading volume of 199,066,591 shares, compared to its average volume of 48,880,762. Incannex Healthcare has a one year low of $0.08 and a one year high of $3.12. The business has a 50 day moving average price of $0.30 and a 200 day moving average price of $0.81. The company has a market cap of $32.02 million, a PE ratio of -0.90 and a beta of 7.47.

Read Our Latest Research Report on IXHL

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in AEye Right Now?

Before you consider AEye, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AEye wasn't on the list.

While AEye currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 “Boring” Mega Cap Stocks to Turn Into Pure Profit
Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines